Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety of SEP-363856 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including KōnanThis study evaluated the safety of SEP-363856 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleAn Ascending Multiple-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SLV-313 Sustained-Release (SR) Tablets Administered Orally to Subjects With Schizophrenia and Schizoaffective Disorder
This study ended early.
Location not clearly listedThis study evaluates the safety of NSA-789 for people with schizophrenia.
This study was withdrawn before enrollment.
In RockvilleThis study evaluated the effectiveness of ITI-007 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockOpen-label Pilot Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia
This study ended early.
In HoustonResearchers compared SM-13496 (lurasidone HCl), placebo and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Tokyo, Etc.This study evaluates the safety and effectiveness of SPG302 for people with schizophrenia.
This study is no longer accepting new participants.
Multiple locations, including Garden GroveRandomised, Parallel-group, Double-blind Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Age-comparable Healthy Volunteers
This study has finished and is no longer accepting participants.
Multiple locations, including La Jolla
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
This study has finished and is no longer accepting participants.
In Nice
A Randomized, Multicenter, 16-week Study to Evaluate the Efficacy and Safety of Two Prescription Digital Therapeutics as an Adjunct to Standard-of-Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including ChandlerA Multicenter, Randomized, Double-blind, Parallel Controlled Study on the Efficacy and Safety of QLM1016 in the Treatment of Schizophrenia
This study is no longer accepting new participants.
In JinanWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.